Castle Biosciences, Inc. (CSTL)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 24.22 |
| Open | 24.38 |
| Bid | 24.22 x 100 |
| Ask | 24.36 x 100 |
| Day's range | 24.18 - 24.93 |
| 52-week range | 9.26 - 26.70 |
| Volume | |
| Avg. volume | 254,704 |
| Market cap | 669.199M |
| Beta (5Y monthly) | 0.93 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
Castle Biosciences to Present at the Leerink Partners Healthcare Crossroads Conference
FRIENDSWOOD, Texas, May 15, 2024--Castle executive management is scheduled to present a company overview at the Leerink Partners Healthcare Crossroads Conference May 29 at 2pm ET.
- Business Wire
Castle Biosciences Expands Evidence Supporting the Performance of its TissueCypher® Barrett’s Esophagus Test in Predicting Future Development of Esophageal Cancer Through Multiple Data Presentations at DDW 2024
FRIENDSWOOD, Texas, May 14, 2024--Castle will share three abstracts related to its TissueCypher® test at DDW 2024.
- Business Wire
Castle Biosciences’ IDgenetix® Test Receives 2024 MedTech Breakthrough Award for "Best Overall Mental Health Solution"
FRIENDSWOOD, Texas, May 10, 2024--Castle awarded the "Best Overall Mental Health Solution" in 8th annual MedTech Breakthrough Awards program for IDgenetix® pharmacogenomic (PGx) test
© 2024 Yahoo. All rights reserved.